Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ISRCTN13494804) titled 'A pilot study to develop a new treatment for people living with Parkinson's who have difficulties with producing and understanding language' on March 9.
Study Type: Interventional
Study Design:
Allocation: N/A: single arm study
Masking: Open (masking not used)
Control: Uncontrolled
Assignment: Single
Purpose: Treatment
Primary Sponsor: University of Strathclyde
Condition:
Parkinson's disease
Nervous System Diseases
Intervention:
Participants will join six weekly individual sessions with an SLT via videoconferencing software such as Microsoft Teams. Each session will last 45-60 minutes.
The sessions will ...